课题基金 / 基金详情

The genetic regulation of natural killer-mediated cell lysis in xenograft

The genetic regulation of natural killer-mediated cell lysis in xenograft
异种移植物中自然杀伤介导的细胞裂解的遗传调控
批准号:
10671258
负责人:
MIYAGAWA Shuji
金额:
$1.98万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1998
资助国家:
日本
项目状态:
已结题
起止时间:
1998 至 1999

项目摘要

项目成果

MIYAGAWA Shuji的其他基金

相关文献

中文摘要
翻译
本研究利用HLA-G和HLA-E基因转染仓鼠卵巢肿瘤细胞(CHO)和猪内皮细胞(SEC),研究了HLA-G和HLA-E对NK细胞直接杀伤活性的影响(G1和G3),制备HLA-E和β2-巨球蛋白,亚克隆入pCAGGS HLA-G(G1)和β2-巨球蛋白(β 2-macroglobulin,β2-macroglobulin)的表达得到证实。此外,β2-微球蛋白与HLA-G1共转染使表达水平提高了数倍。HLA-E的表达用流式细胞仪和北方印迹法检测。用HLA-G的信号肽取代HLA-E的信号肽进行表达,并在CHO或SEC上检测转染分子对NK细胞介导的溶解的改善作用,作为体外不协调异种移植物的延迟型排斥模型。HLA-G1和HLA-E可显著抑制NK细胞介导的SEC裂解,HLA-G和/或HLA-E在细胞表面的表达为克服NK细胞介导的异种移植免疫提供了新的途径。
英文摘要
We have investigated the effect of HLA-G and HLA-E to NK-mediated direct cytotoxicity, using hamster ovarian tumor cells (CHO) or swine endothelial cell (SEC) transfectants with these molecules.At first, cDNA of human full-length HLA-G (G1 and G3), HLA-E and β2-macroglobulin were prepared and subcloned into the pCAGGS (β-actin promoter).The surface expression of HLA-G (G1) and β2-macroglobulin were confirmed. In addition, co-transfection of β2-microglobulin with HLA-G1 enhanced the level of expression by several times. On the other hand, HLA-G3 was not expressed on the SEC surface.Concerning HLA-E, the expression was checked by FACS and northern blot. The signal peptide of HLA-E was substituted with that of HLA-G for certain expression.Amelioration of NK cell-mediated lysis by the transfectant molecules on CHO or SEC was then tested as an in vitro delayed-type rejection model of a discordant xenograft. HLA-G1 and HLA-E significantly suppressed the NK cell mediated SEC lysis.The expression of HLA-G and/or HLA-E on the cell surface serves as a new approach in overcoming NK-mediated immunity to xenografts.
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
K.Matsunami,S.Miyagawa et al.: "The regulation of natural tiller-mediated swine endothelial cell lysis by HLA-G(G1 and G3)"Transplantation Proceedings. (in press).
K.Matsunami、S.Miyakawa 等人:“HLA-G(G1 和 G3)对自然分蘖介导的猪内皮细胞裂解的调节”移植论文集。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
K.Matsunami,S.Miyagawa et al.: "The protection against natural killer-mediated swine endothelial all lysis by HLA-G(G1 and G3) and HLA-E"Transplantation Proceedings. (in press).
K.Matsunami、S.Miyakawa 等人:“HLA-G(G1 和 G3)和 HLA-E 对自然杀伤介导的猪内皮细胞裂解的保护”移植论文集。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
K. Matsunami, S. Miyagawa et al.: "The regulation of natural killer-mediated swine endothelial cell lysis by HLA-G(G1 and G3)"Transplantation Proceedings. (in press).
K. Matsunami、S. Miyakawa 等人:“HLA-G(G1 和 G3)对自然杀伤介导的猪内皮细胞裂解的调节”移植论文集。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
K. Matsunami, S. Miyagawa et al.: "The protection against natural killer-mediated swine endothelial cell lysis by HLA-G(G1 and G3) and HLA-E"Transplantation Proceedings. (in press).
K. Matsunami、S. Miyakawa 等人:“HLA-G(G1 和 G3)和 HLA-E 对自然杀伤介导的猪内皮细胞裂解的保护”移植论文集。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 6 条
    The production of the pigs with an artificial gene (a functional domain-polymeriged nucleotide based on optimal codonusage)
    • 批准号:
      23659612
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.33万
    • 财政年份:
      2011
    • 负责人:
      MIYAGAWA Shuji
    • 依托单位:
    Regulation of the delayed-type xenograft rejectlon and plg retrovIrus研究代表者
    • 批准号:
      18390346
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.32万
    • 财政年份:
      2006
    • 负责人:
      MIYAGAWA Shuji
    • 依托单位:
    The suppression of the delayed-type xenograft rejection
    • 批准号:
      15390377
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $9.41万
    • 财政年份:
      2003
    • 负责人:
      MIYAGAWA Shuji
    • 依托单位:
    Prevention of acute vascular rejection in xenograft
    • 批准号:
      12470239
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $8.96万
    • 财政年份:
      2000
    • 负责人:
      MIYAGAWA Shuji
    • 依托单位: